Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
Adult
Aged
Analysis of Variance
Carcinoma, Ovarian Epithelial
/ mortality
Celiac Artery
/ pathology
Cohort Studies
Cytoreduction Surgical Procedures
/ methods
Databases, Factual
Disease-Free Survival
Female
France
Humans
Kaplan-Meier Estimate
Lymph Node Excision
/ methods
Lymph Nodes
/ pathology
Lymphatic Metastasis
Middle Aged
Multivariate Analysis
Neoplasm Invasiveness
/ pathology
Neoplasm Staging
Ovarian Neoplasms
/ mortality
Prognosis
Retrospective Studies
Risk Assessment
Survival Analysis
Treatment Outcome
Advanced epithelial ovarian cancer
Celiac lymph node status
Peritoneal ovarian carcinomatosis
Porta hepatis disease
Upper abdominal procedures
Journal
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
15
11
2018
revised:
09
02
2019
accepted:
14
02
2019
pubmed:
13
3
2019
medline:
12
6
2020
entrez:
13
3
2019
Statut:
ppublish
Résumé
Completeness of cytoreduction is the most important prognostic factor in patients with advanced ovarian cancer (OC). Extensive upper abdominal surgery has allowed to increase the rate complete cytoreduction and the feasibility of resection of celiac lymph nodes (CLN) and porta hepatis disease in these patients has been demonstrated. The aim of our study was to assess the prognostic impact of CLN involvement in patients with primary advanced OC undergoing a complete cytoreductive surgery (CRS). We designed a retrospective unicentric study. We reviewed data from patients who underwent CLN resection with or without porta hepatis disease resection, within upfront or interval complete CRS in the frontline treatment of advanced epithelial OC between January 2008 and December 2015. Patients were classified in two groups according to CLN status. Univariate and multivariate analyses were conducted. Survival rates were estimated using Kaplan-Meier method. Forty-three patients were included and positive CLN were found in 39.5% of them. The median disease-free survival in the group of patients with positive and negative CLN were 11.3 months and 25.8 months, respectively. In multivariable analysis, both CLN involvement and high peritoneal cancer index were independently associated with decreased disease-free survival. Computed tomography re-reading by an expert radiologist has good sensitivity for detection of positive CLN. CLN involvement and high preoperative tumor burden are independently associated with decreased survival after complete cytoreduction for OC. CLN involvement is a marker of diffuse disease and an independent risk factor for early recurrent disease.
Identifiants
pubmed: 30857876
pii: S0748-7983(19)30289-6
doi: 10.1016/j.ejso.2019.02.018
pii:
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1410-1416Informations de copyright
Copyright © 2019. Published by Elsevier Ltd.